Vibe coding turns software development into a conversation. You focus on the idea, and the AI model handles most of the implementation. Barbara is a tech writer specializing in AI and emerging ...

The hype surrounding AI in software development is undeniable. We are witnessing a paradigm shift, where "vibe coding" — expressing intent in natural language and leveraging AI large language models ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

WordPress’s experimental AI development tool, Telex, has already been put to real-world use, only months after its September debut. At the company’s annual “State of the Word” event on Tuesday in San ...

Python has become one of the most popular programming languages out there, particularly for beginners and those new to the hacker/maker world. Unfortunately, while it’s easy to get something up and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

"Vibe coding may be a horrible, horrible idea from a maintenance standpoint, if you actually tried to make a product," Torvalds said. Reading time 2 minutes Vibe-coding, the AI-assisted form of ...

Google unveils Antigravity, a productivity-focused AI coding IDE. Built on VS Code, it enables instant familiarity and plugin support. Screenshots, recordings, and browser testing power agent ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...